[go: up one dir, main page]

EP3923925A4 - Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation - Google Patents

Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation Download PDF

Info

Publication number
EP3923925A4
EP3923925A4 EP20755994.9A EP20755994A EP3923925A4 EP 3923925 A4 EP3923925 A4 EP 3923925A4 EP 20755994 A EP20755994 A EP 20755994A EP 3923925 A4 EP3923925 A4 EP 3923925A4
Authority
EP
European Patent Office
Prior art keywords
hydroxybutyrate
hydrochloric acid
acid compositions
racemic beta
mixed hydrochloric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP20755994.9A
Other languages
German (de)
English (en)
Other versions
EP3923925A1 (fr
Inventor
Gary MILLET
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Axcess Global Sciences LLC
Original Assignee
Axcess Global Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US16/272,145 external-priority patent/US10736861B2/en
Priority claimed from US16/783,956 external-priority patent/US10973792B2/en
Application filed by Axcess Global Sciences LLC filed Critical Axcess Global Sciences LLC
Publication of EP3923925A1 publication Critical patent/EP3923925A1/fr
Publication of EP3923925A4 publication Critical patent/EP3923925A4/fr
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrrole Compounds (AREA)
  • Confectionery (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EP20755994.9A 2019-02-11 2020-02-10 Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation Pending EP3923925A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/272,145 US10736861B2 (en) 2016-03-11 2019-02-11 Mixed salt compositions for producing elevated and sustained ketosis
US201962805054P 2019-02-13 2019-02-13
US16/720,211 US11020362B2 (en) 2016-03-11 2019-12-19 Beta-hydroxybutyrate mixed salt compositions and methods of use
US16/783,956 US10973792B2 (en) 2019-02-13 2020-02-06 Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
PCT/US2020/017552 WO2020167690A1 (fr) 2019-02-11 2020-02-10 Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation

Publications (2)

Publication Number Publication Date
EP3923925A1 EP3923925A1 (fr) 2021-12-22
EP3923925A4 true EP3923925A4 (fr) 2022-10-19

Family

ID=72044438

Family Applications (1)

Application Number Title Priority Date Filing Date
EP20755994.9A Pending EP3923925A4 (fr) 2019-02-11 2020-02-10 Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation

Country Status (6)

Country Link
EP (1) EP3923925A4 (fr)
JP (2) JP7448555B2 (fr)
CN (1) CN113747890A (fr)
AU (1) AU2020221569B2 (fr)
CA (1) CA3129541A1 (fr)
WO (1) WO2020167690A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL268457B (en) 2019-08-04 2022-05-01 Omega 3 Galilee Ltd Oil- suspension of edible solids and methods of preparing the same
US20220249497A1 (en) * 2021-02-05 2022-08-11 Health Via Modern Nutrition, Inc. Compositions and methods for improving relaxation, sleep, cognition, and/or physical performance
EP4256966A4 (fr) * 2021-06-01 2024-12-11 Osaka Gas Co., Ltd. Composition d'huile et de graisse contenant de l'acide 3-hydroxybutyrique
CN115251375A (zh) * 2022-07-11 2022-11-01 珠海麦得发生物科技股份有限公司 一种(r)-3-羟基丁酸生酮产品及其制备方法
CN115153005A (zh) * 2022-07-27 2022-10-11 南京纽邦生物科技有限公司 β-羟基丁酸组合物
US12059398B2 (en) 2022-08-26 2024-08-13 Health Via Modern Nutrition Inc. Compositions of 1,3-butanediol and beta-hydroxybutyric acid to provide optimal therapeutic ketosis
WO2024067584A1 (fr) * 2022-09-27 2024-04-04 南京纽邦生物科技有限公司 Complexe d'acide 3-hydroxybutyrique et de 3-hydroxybutyrate de sodium et son procédé de préparation

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US20180021274A1 (en) * 2016-07-21 2018-01-25 Savind, Inc. Compositions comprising beta-hydroxybutyric acid and salt, and methods of using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004035417A (ja) * 2002-06-28 2004-02-05 Kao Corp 血中総ケトン体濃度上昇剤
KR20090003148A (ko) * 2006-04-03 2009-01-09 액세라인크 나이와 관련된 기억 손상의 치료를 위한 케톤 생성조성물의 용도
PE20151949A1 (es) * 2013-03-19 2016-01-05 Univ South Florida Composiciones y metodos para producir cetosis elevada y sostenida
CA3021784A1 (fr) * 2016-04-19 2017-10-26 Keto Patent Group, Inc. Administration de butyrate, de beta-hydroxybutyrate et de composes apparentes a des humains
WO2018017667A1 (fr) * 2016-07-20 2018-01-25 Sciadonics, Inc. Formules lipidiques contenant des acides gras bioactifs et d'autres agents bioactifs.
US20180057846A1 (en) * 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
WO2018114309A1 (fr) * 2016-12-23 2018-06-28 Katholieke Universiteit Leuven 3-hydroxybutyrate seul ou en combinaison pour une utilisation dans le traitement de soins d'urgence
EP3654963A4 (fr) * 2017-07-21 2021-04-14 Buck Institute for Research on Aging Énantiomères s de bêta-hydroxybutyrate et de butanediol et leurs procédés d'utilisation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170258745A1 (en) * 2016-03-11 2017-09-14 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US20180021274A1 (en) * 2016-07-21 2018-01-25 Savind, Inc. Compositions comprising beta-hydroxybutyric acid and salt, and methods of using the same

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2020167690A1 *

Also Published As

Publication number Publication date
EP3923925A1 (fr) 2021-12-22
AU2020221569A1 (en) 2021-09-02
JP2022520205A (ja) 2022-03-29
WO2020167690A1 (fr) 2020-08-20
AU2020221569B2 (en) 2025-06-26
JP2024014874A (ja) 2024-02-01
CN113747890A (zh) 2021-12-03
CA3129541A1 (fr) 2020-08-20
JP7448555B2 (ja) 2024-03-12

Similar Documents

Publication Publication Date Title
EP3923925A4 (fr) Compositions de sel-acide mixtes de bêta-hydroxybutyrate racémique et procédés d'utilisation
IL291933A (en) Oligonucleotide compositions and methods of use thereof
PL3761980T3 (pl) Związki aminokwasowe i sposoby zastosowania
EP3704239A4 (fr) Compositions de casz et procédés d'utilisation
EP3704254A4 (fr) Compositions de cas12c et procédés d'utilisation
JP2018172409A5 (ja) １５−ｈｅｐｅを含む組成物および同組成物を使用する方法
EP4061940A4 (fr) Compositions de recombinase et procédés d'utilisation
EP3749343A4 (fr) Formulation et procédé d'utilisation
LT3317281T (lt) (s)-4-(8-amino-3-(1-(but-2-inoil)pirolidin-2-il)imidazo[1,5-a]pirazin-1-il)-n-(piridin-2-il)benzamido kompozicijų kietosios formos
EP3793562C0 (fr) Procédés et compositions pour inhiber la dihydroorotate déshydrogénase
EP3762477C0 (fr) Compositions détergentes enzymatiques solides et procédés d'utilisation et de fabrication
EP3691677A4 (fr) Compositions de conjugués saccharide-polypeptide et leurs procédés d'utilisation
EP3600372A4 (fr) Compositions de synthékine et procédés d'utilisation
EP3668501A4 (fr) Agents anti-parkinson de type sels de pamoate de monoamine, leur procédé de préparation et d'utilisation
EP3568469A4 (fr) Compositions de cellules car-t dirigées contre hla-dr et leurs procédés de fabrication et d'utilisation
EP3600285A4 (fr) Compositions topiques et méthodes de traitement
EP3934426A4 (fr) Compositions de conservation et leurs procédés d'utilisation
EP3518910A4 (fr) Compositions de midodrine et leurs procédés d'utilisation
EP3589326A4 (fr) Composition de gel parodontal et procédé d'utilisation
EP3594220A4 (fr) Composé silicium organique, et procédé de fabrication de celui-ci
EP3601477A4 (fr) Procédés de fabrication et d'utilisation de compositions acides retardées pour la stimulation de puits
EP3790559A4 (fr) Compositions photodynamiques et méthodes d'utilisation
EP3731841A4 (fr) Compositions de cryoconservation de cellules et leurs méthodes d'utilisation
EP3528822A4 (fr) Compositions de maca et procédés d'utilisation
EP3619193A4 (fr) Composés amino-aryl-benzamide et leurs procédés d'utilisation

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210825

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031190000

Ipc: A61K0031120000

A4 Supplementary search report drawn up and despatched

Effective date: 20220921

RIC1 Information provided on ipc code assigned before grant

Ipc: A23L 33/12 20160101ALI20220915BHEP

Ipc: A61P 3/00 20060101ALI20220915BHEP

Ipc: A61K 45/06 20060101ALI20220915BHEP

Ipc: A61K 31/593 20060101ALI20220915BHEP

Ipc: A61K 31/19 20060101ALI20220915BHEP

Ipc: A61K 31/12 20060101AFI20220915BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250131